<?xml version="1.0" encoding="UTF-8"?>
<assessmentItem xmlns="http://www.imsglobal.org/xsd/imsqti_v2p1" identifier="question_10942589" timeDependent="false">
  <responseDeclaration baseType="identifier" cardinality="single" identifier="RESPONSE">
    <correctResponse>
      <value>CHOICE_007</value>
    </correctResponse>
    <mapping lowerBound="0.0">
      <mapEntry mapKey="CHOICE_000" mappedValue="0.0"/>
      <mapEntry mapKey="CHOICE_001" mappedValue="0.0"/>
      <mapEntry mapKey="CHOICE_002" mappedValue="0.0"/>
      <mapEntry mapKey="CHOICE_003" mappedValue="0.0"/>
      <mapEntry mapKey="CHOICE_004" mappedValue="0.0"/>
      <mapEntry mapKey="CHOICE_005" mappedValue="0.0"/>
      <mapEntry mapKey="CHOICE_006" mappedValue="0.0"/>
      <mapEntry mapKey="CHOICE_007" mappedValue="1.0"/>
      <mapEntry mapKey="CHOICE_008" mappedValue="0.0"/>
    </mapping>
  </responseDeclaration>
  <outcomeDeclaration baseType="identifier" cardinality="single" identifier="FEEDBACK"/>
  <outcomeDeclaration baseType="identifier" cardinality="single" identifier="GENERAL_FEEDBACK"/>
  <outcomeDeclaration baseType="float" cardinality="single" identifier="SCORE">
    <defaultValue>
      <value>0</value>
    </defaultValue>
  </outcomeDeclaration>
  <itemBody>
    <choiceInteraction minChoices="1" maxChoices="1" shuffle="false" responseIdentifier="RESPONSE" loChoiceListingType="upper-alpha">
      <prompt>
        <ol>
          <li>
            <div>Haemophilia.</div>
          </li>
          <li>
            <div>Vitamin K deficiency.</div>
          </li>
          <li>
            <div>Thrombocytopenia.</div>
          </li>
          <li>
            <div>Disseminated intravascular coagulation.</div>
          </li>
          <li>
            <div>Von Willebrand's Disease.</div>
          </li>
        </ol>
      </prompt>
      <simpleChoice identifier="CHOICE_000">
        <div>Prolonged prothrombin and partial thromboplastin time</div>
      </simpleChoice>
      <simpleChoice identifier="CHOICE_001">
        <div>Prolonged prothrombin time</div>
      </simpleChoice>
      <simpleChoice identifier="CHOICE_002">
        <div>Prolonged partial thromboplastin time</div>
      </simpleChoice>
      <simpleChoice identifier="CHOICE_003">
        <div>Prolonged partial thromboplastin time and low platelet count</div>
      </simpleChoice>
      <simpleChoice identifier="CHOICE_004">
        <div>Prolonged prothrombin, partial thromboplastin and bleeding time with low platelet count</div>
      </simpleChoice>
      <simpleChoice identifier="CHOICE_005">
        <div>Low platelet count</div>
      </simpleChoice>
      <simpleChoice identifier="CHOICE_006">
        <div>Prolonged prothrombin and bleeding time</div>
      </simpleChoice>
      <simpleChoice identifier="CHOICE_007">
        <div>Prolonged partial thromboplastin and bleeding time</div>
      </simpleChoice>
      <simpleChoice identifier="CHOICE_008">
        <div>Prolonged bleeding time and low platelets</div>
      </simpleChoice>
    </choiceInteraction>
  </itemBody>
  <modalFeedback identifier="CORRECT_FEEDBACK" outcomeIdentifier="GENERAL_FEEDBACK" showHide="show">
    <p>
      <b>Option H (Prolonged partial thromboplastin and bleeding time) is correct.</b>
      Von Willebrand Factor (vWF) has three roles: (i) its expression in the vessel wall binds to the GP1b receptor on the platelet surface, bringing platelets into contact with subendothelium; (ii) independently platelets also contain vWF which becomes available once platelets are activated, assisting in that binding to the subendothelium; (iii) and vWF binds Factor VIII, preventing its destruction, and therefore affects bleeding time and intrinsic pathway.
    </p>
  </modalFeedback>
  <modalFeedback identifier="INCORRECT_FEEDBACK" outcomeIdentifier="GENERAL_FEEDBACK" showHide="show">
    <p>
      <b>Option H (Prolonged partial thromboplastin and bleeding time) is correct.</b>
      Von Willebrand Factor (vWF) has three roles: (i) its expression in the vessel wall binds to the GP1b receptor on the platelet surface, bringing platelets into contact with subendothelium; (ii) independently platelets also contain vWF which becomes available once platelets are activated, assisting in that binding to the subendothelium; (iii) and vWF binds Factor VIII, preventing its destruction, and therefore affects bleeding time and intrinsic pathway.
    </p>
  </modalFeedback>
</assessmentItem>